Wael Metwally
Mr. Wael Metwally is a Consultant ENT Surgeon at the Norfolk and Norwich University Hospitals NHS Trust, UK, distinguished by an exceptional dual qualification in Otolaryngology and Pain Medicine. He holds rigorous German Board Certifications (Facharzt) in both specialties, achieved in 2019 and 2024 respectively, alongside his specialist registration in Germany and the UK.
By integrating surgical expertise in ENT, Mr. Metwally champions a highly specialized, multidisciplinary approach to patient care. His clinical focus centers on pioneering interventional pain managemen of refractory to treat problems within the head and neck region, for instance: Tinnitus, Anosmia, Sudden Sensorineural Hearing Loss and Dysphagia.
Sessions
This session explores the cutting-edge frontier of inner ear therapeutics. We will cover groundbreaking innovations, including gene therapy for hereditary deafness, regenerative medicine for hair cell restoration, and novel drug delivery systems for treating hearing and balance disorders.
Outcome Objectives Participants will be able to:
Describe emerging gene and cell-based strategies for hearing restoration.
Evaluate the potential of next-generation cochlear and vestibular implants.
Identify new pharmacological targets and delivery methods for the inner ear.
Background Sensorineural hearing loss and vestibular disorders have long been considered irreversible. Advances in molecular biology and bioengineering are now challenging this paradigm, creating unprecedented opportunities for biological repair and functional restoration of the inner ear.